Joseph Talamo Receives Stock Award at Intensity Therapeutics Inc (INTS) — SEC Form 4, May 06, 2025
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Joseph Talamo CIK 0001524547 |
CFO
|
Joseph Talamo at Intensity Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Intensity Therapeutics Inc
| 2026-07-20 | Award | — | View |
| 2026-07-01 | Award | — | View |
| 2026-01-05 | Award | — | View |
| 2025-07-02 | Award | — | View |
| 2024-10-23 | Award | — | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F1 | $0.57 | 2025-05-02 | A - Award/Grant | 300,000 A | $0.00 | 2035-05-02 | 300,000 Common Stock | Direct |
Footnotes (1)
- F1
- This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in five, equal, annual installments, beginning on May 2, 2025. Show more
Related filings at Intensity Therapeutics Inc
Other insiders at Intensity Therapeutics Inc
GET /v1/forms/4/0001567264-25-000027
API docs
View Original SEC Filing